Trusted Resources: Education
Scientific literature and patient education texts
The Beginning of the End of Allogeneic Transplantation for Hurler Syndrome
source: The New England journal of medicine
year: 2021
authors: Kharbanda S,Dvorak CC
summary/abstract:Hurler syndrome (mucopolysaccharidosis type I, Hurler variant [MPSIH]) is caused by autosomal recessive mutations in IDUA, leading to absent α-L-iduronidase (IDUA) expression. Deficient clearance of glycosaminoglycans (GAGs) leads to profound systemic manifestations, including neurocognitive impairment. IDUA can be endocytosed from the blood, and enzyme-replacement therapy is available.
However, the enzyme does not cross the blood–brain barrier, and it is therefore only a bridge to definitive treatment, which is best done at as young an age as possible (preferably <12 months and certainly <18 months).1,2 Until now, definitive treatment has been allogeneic hematopoietic-cell transplantation (HCT), because bone marrow–derived monocytes can migrate .
organization: From the Division of Pediatric Allergy, Immunology, and Bone Marrow Transplantation, University of California, San Francisco, San Francisco.DOI: 10.1056/NEJMe2116020
read more
Related Content
-
Are You Considering Stem Cell Transplantation? Questions to Ask Your ProviderStem cell transplantation can be an over...
-
Evidence of Treatment Benefits in Patients With Mucopolysaccharidosis Type I-Hurler in Long-Term Follow-Up Using a N...We developed a brain and spine magnetic ...
-
The MPS I-H Diagnostic Journeyhttps://www.youtube.com/watch?v=jSq5tQD4...
-
Hurler Syndrome Treatment Market Research Prophesied to Grow at a Faster Pace By 2026This Hurler Syndrome Treatment market re...
-
Elizabeth F. Neufeld, PhDBorn in France, Elizabeth Neufeld immigr...
-
Stem Cell Transplant for Bridgnorth Boy With Rare ConditionTwenty-two-month-old Gunner, from Bridgn...
-
Long-Term Evolution of Mucopolysaccharidosis Type I in Twins Treated With Enzyme Replacement Therapy Plus Hematopoie...Mucopolysaccharidoses (MPSs) are a heter...